Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: A prospective double-blind randomized placebo-controlled study

Diabetes Research and Clinical Practice

Volumn 83, Issue 3, 2009, Pages 371-378

  Agrawal, R P ^a   Goswami, Jitender ^a   Jain, Shreyans ^a   Kochar, D K ^a  

^a S P MEDICAL COLLEGE   (India)

Author keywords

Diabetic neuropathy; Glyceryl trinitrate spray; Sodium valproate

Indexed keywords

GLYCERYL TRINITRATE; IBUPROFEN; PLACEBO; SULINDAC; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR NERVE; NAUSEA; NEUROPATHIC PAIN; OVARY POLYCYSTIC DISEASE; PANCREATITIS; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SEDATION; SENSORY NERVE; SIDE EFFECT; THROMBOCYTOPENIA; TREMOR; WEIGHT GAIN;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; FEMALE; GABA AGENTS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; NITROGLYCERIN; PAIN; PAIN MEASUREMENT; PATIENT SELECTION; PLACEBOS; VALPROIC ACID; VASODILATOR AGENTS;

EID: 59349121000     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.12.018     Document Type: Article

References (35)

1. Aptel S.C. Introduction to diabetic neuropathy. Am. J. Med. 107 (1999) 15-85
2. Harati Y. Diabetes and nervous system. Endo. Metab. Clin. North Am. 25 (1996) 325-359
3. Veves A., Backonja M., and Malik R.A. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis and treatment options. Pain Med. 9 6 (2008) 660-674
4. Bulton A.J.M., and Malik R.A. Diabetic neuropathy. Med. Clin. North Am. (1998) 82
5. Low P.A., and Dosto R.R. Symptomatic treatment of painful neuropathy (editorial). JAMA 280 (1998) 1863
6. Jensen P.G., and Larsen J.R. Management of painful diabetic neuropathy. Drugs 18 (2001) 739-749
7. Molina C., Anderson J.W., Ropapot R.M., Woldman S.A., and Murod F. Effects of in vivo nitroglycerine therapy on endothelium dependent and independent relaxation and cyclic GMP accumulation in rat aorta. J. Cardiovasc. Pharamacol. 10 (1987) 371-378
8. Kochar D.K., Rawat N., Agrawal R.P., Vyas A., Beniwal R., Kochar S.K., et al. Sodium valporate for painful diabetic neuropathy: a randomized double blind placebo controlled study. J. Med. 97 (2004) 33-38
9. Chong M.S., and Hester J. Diabetic painful neuropathy: current and future treatment options. Drugs 67 4 (2007) 569-585
10. Max M.B., Culname M., Schafer S.C., Gracely R.H., Walther D.J., Smoller B., et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 37 (1987) 589-596
11. Goldstein D.J., Lv Y., Dekte M.J., Lee T.C., and Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116 (2005) 109-118
12. Rowbotham M.C., Goli V., Kunz N.R., and Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 110 (2004) 697-706
13. Gilron I., and Flatters S.J. Gabapentin and pregabalin for the treatment of neuropathic pain: a review of laboratory and clinical evidence. Pain Res. Manage. 11 (2006) 16A-29A
14. Freeman R., Durso-Decraz E., and Emir B. Efficacy, safety and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses. Diabetes Care 31 7 (2008) 1448-1454
15. Backonja M., Beydown A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetic mellitus. JAMM 280 (1998) 1831-1836
16. Rull J.A., Quiberera R., Gonzalez-Millan H., and Lozano Castañeda O. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial. Diabetologia 5 (1969) 215-218
17. Willon T.D. Tegretol in the treatment of diabetic neuropathy. S. Afr. Med. J. 48 (1974) 869
18. Chakarbarti A.K., and Samantary S.K. Diabetic peripheral neuropathy. Nerve conduction studies before, during and after carbamazepine therapy. Aust. N. Z. Med. 6 (1976) 565-568
19. Capsaicin Study Group. Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Diabetes Care 15 (1992) 159-165.
20. Boulton A.J.M., Levin S., and Comstock J. A multicentre trial of the aldose reductase inhibitor tolerastat in patients symptomatic neuropathy. Diabetologia 33 (1990) 431-437
21. Crepaldi G., Fedele D., Tiengo A., Battistin L., Negrin P., Pozza G., et al. Ganglioside treatment in diabetic peripheral neuropathy: a multicenter trial. Acta Diabetol. Lat. 10 (1983) 265-276
22. Dejgard A., Peterson P., and Kastrup J. Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet 1 (1988) 9-11
23. Dyck P.J. Nerve growth factor and diabetic neuropathy. Lancet 348 (1996) 1044-1045
24. Viola V., Newnham H.H., and Simpson R.W. Treatment of intractable painful diabetic neuropathy with intravenous lignocaine. J. Diabetes Complications 20 (2006) 34-39
25. Watson C.P., Moulin D., Watt-Watson J., Gordan A., and Eisenhoffer J. Controlled release of oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 105 (2003) 71-78
26. Harati Y., Gooch C., Swenson M., Edelman S.V., Greene D., Raskin P., et al. Maintenance of the long term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J. Diabetes Complications 14 (2000) 65-70
27. Barbano R.L., Herrmann D.N., Hart-Gouleav S., Pennella-Vaughan J., Lodewick P.A., and Dworkin R.H. Effectiveness, tolerability and impact on quality of life of the 5% lidocaine patch in diabetic neuropathy. Arch. Neurol. 61 (2004) 914-918
28. Cohen K.L., and Harris S. Efficacy and safety of non-steroidal anti-inflammatory drugs in the therapy of diabetic neuropathy. Arch. Intern. Med. 147 (1987) 1442-1444
29. Rayman G., Baker N.R., and Krishan Singhan T.M. Glyceryl trinitrate patches as an alterantive to isosorbide dinitrate spray in the treatment of chronic painful diabetic neuropathy. Diabetes Care 9 (2003) 2697-2698
30. Agrawal R.P., Choudhary R., Sharma P., Sharma S., Beniwal R., Kaswan K., et al. Glyceryl trinitrate spray in the management of painful diabetic neuropathy: a randomized double blind placebo controlled cross over study. Diabetes Res. Clin. Pract. 77 (2007) 161-167
31. Kochar D.K., Jain N., Agrawal R.P., Srivastava T., Agrawal R.P., and Gupta S. Sodium valproate in the management of painful neuropathy in type-2 diabetes-a randomized placebo controlled study. Acta Neurol. Scand. 106 (2002) 248-252
32. Melzack R., and Wall P.D. Pain mechanisms a new theory. Science 150 (1965) 971-979
33. Archer A.G., Watkins P.J., Thomas P.K., Sharma A.K., and Payan J. Natural history of acute painful neuropathy in diabetes mellitus. J. Neurol. Neurosurg. Psychiatry 46 (1983) 491-499
34. Cutrer F.M., Limmeroth V., and Moskowitz M.A. Possible mechanisms of valproate in migraine prophylaxis. Cephalagia 17 (1997) 93-100
35. Chong M.S., Smith T.E., and Hanna M. Anticonvulsants for the management of pain. Euro. Pain J. 2 (2002) 5-18